Upcoming events

    • 06 Sep 2024
    • 3:00 PM - 5:00 PM
    • Zoom
    Register

    Emerging Clinical Applications for Psychedelic Therapy

    2 CE Hours available (APA approved)

    Date: Sept. 6th, 2024
    Time: 3 p.m. – 5 p.m.

    Member: $78
    Nonmember: $120*

    Limited Time New Member Course Discount of 50%: If you sign up as a new member today ($155 Full Membership for first year), you’ll receive a discount code to register for the course for only $39.

    Webinar Description

    In this presentation, Dr. Barnett will describe various psychedelic compounds, their known mechanisms of action, and various subjective effects. He will review the past and current literature on the potential therapeutic benefits, as well as the risks, of psychedelic medicines on a variety of clinical conditions. Finally, he will discuss “trends and issues” in the broader psychedelic medicine field with a look at future directions. Discussion may also include psychedelic experiences outside of Western medical and research models, such as personal use, indigenous traditions, and religious use.

    Objectives

    1. List the names and differential subjective and physiological effects of at least four psychedelic substances.

    2. Explain the basic pharmacological action of at least 3 psychedelic medicines.

    3. Compare the potential risks and benefits of psychedelic experiences.

    4. Describe at least 4 clinical conditions shown to be improved by at least two psychedelic compounds.

    About the Speaker

    Dr. Rick Barnett, Psy.D.  


    Dr. Rick Barnett, Psy.D., is a licensed clinical psychologist and a licensed alcohol and drug counselor with an MS in Clinical Psychopharmacology. He operates a private group practice specializing in adults, older adults, and state-mandated patients with alcohol and other drug use disorders.

    Dr. Barnett has served as President of APA Division 55 in 2020 and President of the Vermont Psychological Association from 2011 to 2014. He is currently the Chair of the Legislative Committee, focusing on Prescriptive Authority in Vermont.

    In 2021, he co-founded the Psychedelic Society of Vermont after completing a yearlong training in psychedelic psychotherapy and research through the California Institute for Integral Studies (CIIS). Additionally, he is the Founder and CEO of CARTER, Inc., a 501(c)(3) nonprofit organization dedicated to the art and science of achieving lifelong freedom from addictive disorders.

    Dr. Barnett was recently appointed Chair of the Psychedelic Therapy Advisory Group, as established by Act 126 in Vermont in 2024

    • 18 Oct 2024
    • 9:00 AM - 4:15 PM
    • Zoom
    Register

    Sequence XIV: Ethics and Risk Management of Navigating New Frontiers in Psychological Practice

    6 CE Hours available (APA approved)

    Date: October 18, 2024
    Time: 9 a.m. – 4:15 p.m.
    10-minute breaks each hour and a 30-minute lunch break

    Member: $78
    Nonmember: $120*

    Limited Time New Member Course Discount of 50%: If you sign up as a new member today ($155 Full Membership for first year), you’ll receive a discount code to register for the course for only $39.

    Workshop Description

    For over two decades, the Trust has worked to educate and support psychologists in improving their ethics and risk management skills and strategies by providing live workshops, webinars, risk management consultations, and expanding resources. This 14th Workshop in our Sequence series continues to emphasize applied, integrated, and strategic methods to help you stay grounded in ethical principles and practices, and to protect you from adverse disciplinary and legal actions.

    In today’s swiftly changing landscape, psychologists are witnessing a surge of fresh opportunities and possibilities. These emerging frontiers not only broaden the scope of professional activities for aiding clients and patients through innovative methods, but also offer avenues to enhance and support practice in ways that were once unimaginable. However, these new territories also come with their own set of unique challenges, unforeseen risks, and uncertainties.

    Workshop XIV is dedicated to exploring the ethical considerations and risk management strategies essential for effectively maneuvering through these novel domains in psychological practice. Specific topics include:

    • Necessary considerations for expanding one’s practice into new areas
    • Psychedelic assisted therapy (PAT)
    • The use of artificial intelligence (AI) in psychological practice
    • Issues related to digital security, new understandings of PSYPACT and inter-jurisdictional telepsychology (IJTP)
    • Effectively managing transitions in one’s practice (e.g., new employment, retirement, disability/illness, professional wills)

    Objectives

    • Describe basic principles of ethics and risk management, as applied to several specific clinical situations that arise in professional practice.
    • List at least three areas of the ethics code relevant to expanding one’s psychological practice into new directions.
    • Describe potential risks psychologists face when growing their business in new areas.
    • Summarize at least three risk management strategies that can assist in mitigating risk.
    • Explain the current state of legality regarding this model of treatment; identify areas of unique risk when practicing PAT; and delineate at least five specific strategies for ethically managing those risks.
    • Define psychedelic assisted therapy (PAT).
    • Differentiate between legal and illegal interjurisdictional telepsychology (IJTP) practice and explain multiple avenues for legal practice.
    • Define three benefits and three risks of using artificial intelligence in psychological practice.
    • Identify three aspects of HIPAA that apply to privacy and security in emerging technology.
    • Summarize four steps in preparing for transitions in professional practice, and three action steps when these changes occur.
    • Delineate at least four risk management strategies for IJTP, both within and outside of PSYPACT, including the management of patients in crisis across jurisdictions.

    About the Speaker

    Leisl M. Bryant, Ph.D., ABPP

    Dr. Bryant is a licensed New Hampshire and Massachusetts-based clinical and forensic psychologist, with board certification in Forensic Psychology by the American Board of Professional Psychology. She received her B.A. from the University of West Florida, her M.A. and Ph.D. in clinical psychology from Duquesne University, and completed a forensic postdoctoral fellowship at the University of Massachusetts Medical School Law and Psychiatry Program.

    Working in both criminal and civil arenas, Dr. Bryant has maintained a private practice in clinical and forensic psychology for nearly two decades and has provided psychological services in a variety of forensic and therapeutic settings.

    Dr. Bryant is a Fellow with the American Academy of Forensic Psychology, and formerly served as President and Executive Director of the New Hampshire Psychological Association (NHPA). She also served on the NHPA Ethics Committee for over ten years, received the Margaret M. Riggs Award for Distinguished Contribution to Psychology in the State of New Hampshire, and was awarded the Karl F. Heiser APA Presidential Award for Advocacy. Dr. Bryant brings extensive experience in forensic, clinical, and ethical consultation, academic instruction, and professional presentation to her role on the risk management team.

    Working in both criminal and civil arenas, Dr. Bryant has maintained a private practice in clinical and forensic psychology for nearly two decades and has provided psychological services in a variety of forensic and therapeutic settings.

    Dr. Bryant is a Fellow with the American Academy of Forensic Psychology, and formerly served as President and Executive Director of the New Hampshire Psychological Association (NHPA). She also served on the NHPA Ethics Committee for over ten years, received the Margaret M. Riggs Award for Distinguished Contribution to Psychology in the State of New Hampshire, and was awarded the Karl F. Heiser APA Presidential Award for Advocacy. Dr. Bryant brings extensive experience in forensic, clinical, and ethical consultation, academic instruction, and professional presentation to her role on the risk management team.

    Event Details

    Sequence XIV: Ethics and Risk Management of Navigating New Frontiers in Psychological Practice is sponsored by The Trust. The Trust is approved by the American Psychological Association to sponsor continuing education for psychologists. The Trust maintains responsibility for this program and its content.

    IMPORTANT NOTICE: Please note that APA CE rules require that we only give credit to those who attend the entire workshop. Those arriving more than 15 minutes after the scheduled start time or leaving before the workshop is completed will not receive CE credits and will not be eligible for the 15% premium discount.

    Eligibility for Insurance Premium Discounts

    Workshop completion earns 6 CE credits and eligibility to receive a 15% premium discount on your Trust Sponsored Professional Liability Insurance for your next 2 consecutive policy periods. To obtain CE discounts, submit CE certification from an organization approved by APA to offer CE credit (must have been completed within the previous 15 months) with the insurance application. Discounts cannot be combined and are not applicable to Researcher/Academician or Student policies. Group policies become eligible for the CE discount when at least 50% of those insured under the group policy submit CE certification. All applications are individually underwritten and submission of CE certification will not guarantee insurance policy issuance or renewal.

    Continuing Education Grievance Policy

    The Trust is fully committed to conducting all activities in strict conformance with the American Psychological Association’s Ethical Principles of Psychologists. The Trust will comply with all legal and ethical guidelines for non-discrimination in promotional activities, program content and in the treatment of CE participants. The Trust CE Director is responsible for complying with these standards.

    While the Trust strives to assure fair treatment for all participants and to anticipate problems before they occur, occasionally grievances may be filed. In cases where a participant files a written or oral grievance, the following actions are taken:

    • If the grievance concerns the content of the workshop, webinar, book, or the continuing education test, a Trust representative will mediate and will be the final arbitrator. If the participant requests action, the CE Director or a Trust representative will either provide a credit for a subsequent CE offering or provide a partial or full refund of the CE fee already paid.

    • Actions involving a credit or a refund will require a written note documenting the grievance for record-keeping purposes. The aggrieved individual need not sign the note. If the grievance specifically concerns The Trust, the CE Director or Trust representative will attempt to arbitrate.

    Direct correspondence to:

    Continuing Education
    The Trust
    111 Rockville Pike, Suite 700
    Rockville, MD 20850
    Phone: (800) 477-1200
    Email: grievances@trustinsurance.com

Past events

03 Nov 2023 Embracing a Culture of Equity, Inclusion, and Community
15 Sep 2023 The Trust Workshop Webinar
28 Apr 2023 Use of Attachment-Based Family Therapy for Adolescents Struggling with Depression and Suicidal Thoughts
31 Mar 2023 Latinx, Acculturation & Rural United States: Ethical Considerations
04 Nov 2022 Annual Conference: Meeting the Rising Demand for the Treatment of Child & Adolescent Anxiety and Trauma
26 Aug 2022 Don’t Let the “TR” Fool You: The DSM-5-TR is Far More Than a Text Revision
27 May 2022 Ethical Supervision of Psychology Trainees
01 Apr 2022 The Evolving Dynamics of the Duty to Warn
12 Nov 2021 [Half Day PM] Social and Emotional Impacts of the Pandemic: Reshaping the Practice of Psychology
12 Nov 2021 [Full Day In-Person] Social and Emotional Impacts of the Pandemic: Reshaping the Practice of Psychology
12 Nov 2021 [Half Day AM] Social and Emotional Impacts of the Pandemic: Reshaping the Practice of Psychology
12 Nov 2021 [Full Day Virtual] Social and Emotional Impacts of the Pandemic: Reshaping the Practice of Psychology
17 Sep 2021 The Psychology of Conspiracy Theories
25 Jun 2021 Diagnosis of ASD in Adults: A Spectrum of Symptom Manifestation
21 May 2021 The Impact Of The Cultural Divide On The Practice Of Psychotherapy
13 Nov 2020 Equity, Diversity and Inclusion Panel: Listening Session supporting the Psychological Resilience of Underserved Communities
13 Nov 2020 MePA Annual Conference: Building Diverse & Psychologically Resilient Communities
02 Oct 2020 Webinar: Sequence IX: Ethics & Risk Management in Complex Clinical Conundrums
18 Sep 2020 Working with the LGBTQA+ Community Across the Lifespan
26 Jun 2020 Webinar: Telepsychology Considerations for Practice in a COVID-19 World
15 Nov 2019 Intimate Partner Violence, Abuse, and Anger: Critical Issues in Case Formulation and Treatment
20 Sep 2019 Psychotherapy in a Tumultuous Sociopolitical Climate
31 May 2019 Navigating through Loss and Grief: How Continuing Bonds, Creativity, Religion/Spirituality and Culture Contribute to the Journey
09 Nov 2018 Telehealth and Psychotherapy: Best Practices, Current Research and Ethical Considerations
14 Sep 2018 Navigating a Board Complaint: What’s the Process and How to Deal with It? A Morning with the Chair of the Board of Examiners and a Legal Expert
22 Jun 2018 Psychopharmacology Update: How Medications Work, Effective Collaboration with Prescribers, and Current Ethical Guidance
10 Nov 2017 Mood Assessment 2.0: Improved Accuracy, Treatment Selection and Outcomes
02 Jun 2017 “Out of Practice? Into Retirement: A Guide for Psychologists”
18 Nov 2016 Treating Chronic Pain: Evolving Models of Care
07 Oct 2016 The Medicare Authorization and CHIP Reauthorization Act of 2015 (MACRA)– What Does it Mean for You?
01 Jul 2016 Therapeutic Risk Management: Assessing and Addressing Suicidal Thoughts and Behaviors Among Those at Risk for Self-Directed Violence
08 Apr 2016 "Supervision" Workshop, Featuring Mark W. Steege, Ph.D.